CD47 Targeting Therapeutics Market Analysis Driving Innovation in Cancer Immunotherapy
The CD47 Targeting Therapeutics Market Analysis highlights the increasing interest in innovative cancer treatment strategies based on immunotherapy. CD47 is a protein found on the surface of many cells that acts as a “don’t eat me” signal to the immune system, preventing immune cells from destroying them. However, many cancer cells exploit this mechanism by overexpressing CD47...
0 Commenti 0 condivisioni 21 Views 0 Anteprima